SCHEMBL29617722

SCHEMBL29617722

COc1cc2ccccc2cc1C(=O)NCc1ccc(B(O)O)cc1

nearest known ligand 0.74

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.53
TP53 P04637 1/20 0.53
GLA P06280 1/20 0.53
RXFP1 Q9HBX9 2/20 0.53
MEN1 O00255 5/20 0.52
KMT2A Q03164 5/20 0.52
ALDH1A1 P00352 3/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
KDM4E B2RXH2 2/20 0.50
LMNA P02545 2/20 0.50
HTT P42858 2/20 0.50
NPC1 O15118 2/20 0.50
TRPV1 Q8NER1 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
RAB9A P51151 1/20 0.49
PPARG P37231 1/20 0.49
PPARA Q07869 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18641751 1.00 HPGD (0.53) HPGDTP53GLARXFP1MEN1
SCHEMBL17339636 0.85 HPGD (0.74) HPGDTP53GLAMEN1KMT2A
SCHEMBL28239400 0.82 HPGD (0.56) HPGDTP53GLARXFP1MEN1
SCHEMBL17339512 0.82 HPGD (0.55) HPGDTP53GLARXFP1MEN1
SCHEMBL5785228 0.82 HPGD (0.67) HPGDTP53GLAMEN1KMT2A
SCHEMBL17339443 0.81 HPGD (0.63) HPGDTP53GLARXFP1MEN1
SCHEMBL29617795 0.81 LMNA (0.62) HPGDALDH1A1LMNAPPARA
SCHEMBL17339437 0.81 LMNA (0.62) HPGDALDH1A1LMNAPPARA
SCHEMBL17339241 0.81 HPGD (0.53) HPGDTP53GLAMEN1KMT2A
SCHEMBL17339271 0.81 AKR1B1 (0.54) HPGDTP53GLAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114685516-A Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-07-01 CN disclosed
CN-108431007-B Pyrazolopyrimidine derivatives as BTK inhibitors for the treatment of cancer 洛克索肿瘤学股份有限公司 2022-06-07 CN disclosed